Inovio Pharmaceuticals Long. Inovio Pharmaceuticals is one of many pharmaceutical companies running a drug race at Covid19. Currently, the market has moved upwards, confirming the positive mood of investors, due to the conclusion of an agreement between Inovio and Advaccine on a license agreement for the production and sale of the INO-4800 vaccine in China. And there is no bigger market than China. CA analysts expect a gradual rise in price, taking into account the average volatility to values around $ 20 per CFD, a share.
Chart source: WebTrader